MainboardGMP
LIVE
LIVE GMP
Watrana Rentals Ltd₹+65·Mahanadi Coalfields Ltd₹0·Integris Medtech₹0·Foodlink F&B Holdings (India)₹+12·Shree Siddhivinayak Greentech Industries₹0·Crystal Crop Protection Ltd₹+14·Vedant Poly Fabs Ltd₹0·Johnsoncab Electricals Ltd₹+5·HGS (India) Ltd₹+38·Vectras Enprocon Ltd₹0·Maxwell Engineering Solutions Ltd₹+82·Antala Industries Ltd₹0·Bombay Coated & Special Steels Ltd₹+8·Carver Roboweld Ltd₹0·Ajwa Projects Ltd₹0·Watrana Rentals Ltd₹+65·Mahanadi Coalfields Ltd₹0·Integris Medtech₹0·Foodlink F&B Holdings (India)₹+12·Shree Siddhivinayak Greentech Industries₹0·Crystal Crop Protection Ltd₹+14·Vedant Poly Fabs Ltd₹0·Johnsoncab Electricals Ltd₹+5·HGS (India) Ltd₹+38·Vectras Enprocon Ltd₹0·Maxwell Engineering Solutions Ltd₹+82·Antala Industries Ltd₹0·Bombay Coated & Special Steels Ltd₹+8·Carver Roboweld Ltd₹0·Ajwa Projects Ltd₹0·
Home › IPOs › Integris Medtech › Issue Details
IN
Integris Medtech
UPCOMING NSE & BSE Bookbuilding IPO Fresh capital cum OFS Integris Medtech IPO GMP
GREY MARKET PREMIUM
₹ 0
No premium data
EST. LISTING PRICE
—
Issue Price: ₹ 0
Issue Price
₹0
Face Value
₹1
Lot Size
0 shares
IPO Size
Agg. upto ₹600 Cr
Open Date
27 Nov 2026
Close Date
01 Dec 2026
Allotment
02 Dec 2026
Listing Date
04 Dec 2026
Exchange
NSE & BSE

Integris Medtech IPO Details: Price, Dates & Financials

The Integris Medtech IPO pre-issue shareholding stands at 108,338,049 shares. The Integris Medtech IPO size is up to ₹600 crore.

Issue Details
Pre-Issue Shareholding
108,338,049 shares
IPO Size
Agg. upto ₹600 Cr
Integris Medtech IPO Issue Details FAQs
Pre-issue shareholding: 108,338,049 shares.
Integris Medtech IPO is a Fresh capital cum OFS issue. Issue type: Bookbuilding IPO. Face value is ₹1.
The Red Herring Prospectus (RHP) of Integris Medtech IPO is available on the website of the lead manager and the stock exchange (NSE & BSE) — see the lead manager links on the main page.
The DRHP is the initial offer document filed for regulatory review, while the RHP includes updated disclosures, final issue details, and the price band (when announced). Comparing both documents helps investors identify changes in the Integris Medtech IPO's financial information, risks, and offer terms before investing in the Integris Medtech IPO. Reviewing both documents provides a clearer understanding of the Integris Medtech IPO before making an investment decision.
The DRHP and RHP of the Integris Medtech IPO disclose potential risks related to the company's business, financial performance, legal matters, and industry conditions. Reviewing these documents helps investors identify potential concerns about the Integris Medtech IPO, evaluate the Integris Medtech IPO's risk factors, and make a more informed decision before investing in the Integris Medtech IPO.

GMP and IPO data are unofficial and for information only — not investment advice. Read the full disclaimer.